https://www.selleckchem.com/mTOR.html
Moreover, GTPBP4 was identified as direct downstream target of miR-873-5p in HCC cells and FGD5-AS1mediated the effects of GTPBP4 by competitively binding with miR-873-5p. Taken together, this study demonstrated the regulatory role of FGD5-AS1 in the progression of HCC and identified the miR-873-5p/GTPBP4 axis as the direct downstream pathway. It represents a promising novel therapeutic strategy for HCC patients. There is a knowledge gap about how much physical activity is recommended to patients with chronic obstructive pulmonary disease (COPD). W
Mi piace
Commento
Condividi
